Return On Assets of Transcode Therapeutics, Inc. from 31 Mar 2022 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Transcode Therapeutics, Inc. quarterly and annual Return On Assets in % history and change rate from 31 Mar 2022 to 30 Sep 2025.
  • Transcode Therapeutics, Inc. Return On Assets for the quarter ending 30 Sep 2025 was -319%, a 14% decline year-over-year.
  • Transcode Therapeutics, Inc. annual Return On Assets for 2024 was -287%, a 4% decline from 2023.
  • Transcode Therapeutics, Inc. annual Return On Assets for 2023 was -276%, a 107% decline from 2022.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Transcode Therapeutics, Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -319% -38% -14% 01 Jul 2025 30 Sep 2025
Q2 2025 -301% -41% -16% 01 Apr 2025 30 Jun 2025
Q1 2025 -349% -110% -46% 01 Jan 2025 31 Mar 2025
Q4 2024 -287% -11% -4% 01 Oct 2024 31 Dec 2024
Q3 2024 -281% -14% -5.1% 01 Jul 2024 30 Sep 2024
Q2 2024 -260% -21% -8.8% 01 Apr 2024 30 Jun 2024
Q1 2024 -239% -47% -24% 01 Jan 2024 31 Mar 2024
Q4 2023 -276% -143% -107% 01 Oct 2023 31 Dec 2023
Q3 2023 -268% -178% -198% 01 Jul 2023 30 Sep 2023
Q2 2023 -239% -174% -266% 01 Apr 2023 30 Jun 2023
Q1 2023 -192% -158% -466% 01 Jan 2023 31 Mar 2023
Q4 2022 -134% 01 Oct 2022 31 Dec 2022
Q3 2022 -90% 01 Jul 2022 30 Sep 2022
Q2 2022 -65% 01 Apr 2022 30 Jun 2022
Q1 2022 -34% 01 Jan 2022 31 Mar 2022

Transcode Therapeutics, Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -287% -11% -4% 01 Jan 2024 31 Dec 2024
2023 -276% -143% -107% 01 Jan 2023 31 Dec 2023
2022 -134% 01 Jan 2022 31 Dec 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.